**Core Concept**
Hodgkin's lymphoma is a type of cancer of the lymphatic system, characterized by the presence of Reed-Sternberg cells. The treatment protocol for Hodgkin's lymphoma typically involves a combination of chemotherapy, radiation therapy, and in some cases, immunotherapy. The goal of treatment is to eliminate the cancer cells while minimizing harm to the patient.

**Why the Correct Answer is Right**
The treatment protocol for Hodgkin's lymphoma is well-established and involves a combination of chemotherapy agents, including ABVD (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine). Other chemotherapy agents such as ESHAP (Etoposide, Methylprednisolone, Cytarabine, and Cisplatin) may also be used in certain situations. The choice of chemotherapy agent depends on various factors, including the stage and type of Hodgkin's lymphoma, as well as the patient's overall health and tolerance to treatment.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a commonly used chemotherapy agent in the treatment protocol for Hodgkin's lymphoma.
* **Option B:** This option is incorrect because it is a chemotherapy agent that is commonly used in the treatment of non-Hodgkin's lymphoma, but not typically used in Hodgkin's lymphoma.
* **Option C:** This option is incorrect because it is a radiation therapy technique, not a chemotherapy agent.
* **Option D:** This option is incorrect because it is an immunotherapy agent, not a chemotherapy agent.

**Clinical Pearl / High-Yield Fact**
The ABVD chemotherapy regimen has become the standard of care for Hodgkin's lymphoma due to its effectiveness and relatively low toxicity profile. It is essential to recognize the importance of chemotherapy in the treatment of Hodgkin's lymphoma and to be familiar with the various chemotherapy agents used in its treatment.

**Correct Answer:** B.